Falklands Business Journal
SEE OTHER BRANDS

Fresh news on business and economy in the Falkland Islands

Falklands Business Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Falklands Business Journal.

Press releases published on May 28, 2025

Nasdaq Executives to Present at Upcoming Investor Conferences

Nasdaq Executives to Present at Upcoming Investor Conferences

NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conferences in June with webcasts available at Nasdaq’s Investor Relations website: ir.nasdaq.com/events.cfm. Who: Adena Friedman, Chair and CEO, Nasdaq …

LPL Financial to Present at the William Blair Growth Stock Conference

LPL Financial to Present at the William Blair Growth Stock Conference

SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- LPL Financial LLC (Nasdaq:LPLA) today announced that Matt Audette, President and Chief Financial Officer, will present at the William Blair Growth Stock Conference on June 4. The presentation takes place at 11 a. …

Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference

Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference

FREMONT, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Goldman Sachs 46th Annual Global Healthcare Conference in …

Financial Institutions, Inc. Announces Quarterly Cash Dividend

Financial Institutions, Inc. Announces Quarterly Cash Dividend

WARSAW, N.Y., May 28, 2025 (GLOBE NEWSWIRE) -- Financial Institutions, Inc. (Nasdaq: FISI) (the “Company”), parent company of Five Star Bank and Courier Capital, LLC, announced today that its Board of Directors has approved a quarterly cash dividend of $0. …

ORIC® Pharmaceuticals Announces $125 Million Private Placement Financing

ORIC® Pharmaceuticals Announces $125 Million Private Placement Financing

Financing led by SR One and includes participation from new and existing investors, including Point72, Viking Global Investors, Venrock Healthcare Capital Partners, New Enterprise Associates (NEA), Nextech, Vivo Capital, and NEXTBio Capital Pro forma cash …

Brilliant Earth Announces Participation in the TD Cowen 9th Annual Future of the Consumer Conference and Noble Capital Markets Emerging Growth Virtual Equity Conference

Brilliant Earth Announces Participation in the TD Cowen 9th Annual Future of the Consumer Conference and Noble Capital Markets Emerging Growth Virtual Equity Conference

SAN FRANCISCO, May 28, 2025 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (NASDAQ: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced that the Company will participate in upcoming …

ORIC® Pharmaceuticals Announces Potentially Best-In-Class Preliminary Efficacy and Safety Data from Ongoing Phase 1b Trial of ORIC-944 in Combination with AR Inhibitors for the Treatment of Patients with mCRPC

ORIC® Pharmaceuticals Announces Potentially Best-In-Class Preliminary Efficacy and Safety Data from Ongoing Phase 1b Trial of ORIC-944 in Combination with AR Inhibitors for the Treatment of Patients with mCRPC

Broad and deep PSA responses achieved, with 59% PSA50 response rate (confirmed rate of 47%, and one additional response pending confirmation) and 24% PSA90 response rate (all confirmed) in patients with mCRPC       PSA responses were observed across all …

nCino Reports First Quarter Fiscal Year 2026 Financial Results

nCino Reports First Quarter Fiscal Year 2026 Financial Results

•  Total Revenues of $144.1M, up 13% year-over-year •  Subscription Revenues of $125.6M, up 14% year-over-year WILMINGTON, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking …

Sanuwave Health Appoints Greg Bazar to Board of Directors

Sanuwave Health Appoints Greg Bazar to Board of Directors

EDEN PRAIRIE, Minn., May 28, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (Nasdaq:SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce the addition of Greg Bazar to its Board …

Amaero Provides Update to Financial Guidance, Largely Reaffirming Expectations

Amaero Provides Update to Financial Guidance, Largely Reaffirming Expectations

~ Revenue to Accelerate in Current Quarter with a Continuation of Growth into FY 2026 ~ ~ Company Expects to be EBITDA Positive in FY 2027 ~ MCDONALD, Tenn., May 28, 2025 (GLOBE NEWSWIRE) -- Amaero Ltd (ASX:3DA) (OTCQB: AMROF) (“Amaero” or the “Company”), …

XCEL BRANDS, INC. Receives NASDAQ notice regarding delinquent Form 10-K and Form 10-Q filing

XCEL BRANDS, INC. Receives NASDAQ notice regarding delinquent Form 10-K and Form 10-Q filing

NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), today announced that on May 22, 2025, it received a delinquency notification letter from the Nasdaq Stock Market LLC ("Nasdaq") indicating that since …

Outdoor Holding Company Announces Settlement and Leadership Transition

Outdoor Holding Company Announces Settlement and Leadership Transition

Board Appoints Steve Urvan, Founder of GunBroker.com and Largest Shareholder, as Chairman and CEO Announces Regained Compliance with Nasdaq Listing Rule Regarding Timely Periodic Reporting SCOTTSDALE, Ariz., May 28, 2025 (GLOBE NEWSWIRE) -- Outdoor Holding …

Sana Biotechnology to Present at June 2025 Investor Conferences

Sana Biotechnology to Present at June 2025 Investor Conferences

SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in June. …

Core Specialty Announces Changes to its Board of Directors

Core Specialty Announces Changes to its Board of Directors

CINCINNATI, May 28, 2025 (GLOBE NEWSWIRE) -- Core Specialty Insurance Holdings, Inc. and its subsidiaries (“Core Specialty” or the “Company”) announced today that Patrick Gordon has been appointed to the Board of Directors of the Company effective …

Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

DALLAS, May 28, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the …

argenx Announces Results of Annual General Meeting of Shareholders

argenx Announces Results of Annual General Meeting of Shareholders

May 28, 2025 – 10:01 PM CET Amsterdam, the Netherlands – argenx SE (Euronext …

Nutanix Reports Third Quarter Fiscal 2025 Financial Results

Nutanix Reports Third Quarter Fiscal 2025 Financial Results

  Delivers Outperformance Across All Guided Metrics Reports 18% YoY ARR Growth and Strong Free Cash Flow SAN JOSE, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced financial …

Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress

Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress

PHILADELPHIA, May 28, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today …

Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference

Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with investors and …

Disc Medicine to Participate in Upcoming Investor Conferences

Disc Medicine to Participate in Upcoming Investor Conferences

WATERTOWN, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service